BETTER THERAPEUTICS INC's ticker is and the CUSIP is 08773T104. A total of 16 filers reported holding BETTER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $38,640 | -78.9% | 198,154 | -60.4% | 0.00% | – |
Q3 2023 | $182,962 | -61.4% | 499,897 | +14.0% | 0.00% | – |
Q2 2023 | $473,557 | +54.3% | 438,479 | 0.0% | 0.00% | – |
Q1 2023 | $306,935 | -36.1% | 438,479 | +0.9% | 0.00% | – |
Q4 2022 | $480,431 | -37.2% | 434,779 | +0.0% | 0.00% | – |
Q3 2022 | $765,000 | +47.1% | 434,644 | +30.3% | 0.00% | – |
Q2 2022 | $520,000 | -7.6% | 333,546 | +17.3% | 0.00% | – |
Q1 2022 | $563,000 | -40.5% | 284,395 | +39.6% | 0.00% | – |
Q4 2021 | $947,000 | – | 203,762 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $1,560,000 | 0.01% |
Tower Research Capital LLC (TRC) | 14,627 | $23,000 | 0.00% |
NORTHERN TRUST CORP | 16,703 | $26,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Aspire Private Capital, LLC | 200 | $0 | 0.00% |
PSI Advisors, LLC | 65 | $0 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 73,800 | $115,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 37,944 | $59,000 | 0.00% |
BlackRock Inc. | 75,948 | $118,000 | 0.00% |
Citadel Advisors | 108,900 | $170,000 | 0.00% |